Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bio Rad Laboratories Inc (NYSE:BIO)

222.50
Delayed Data
As of Jun 23
 -0.85 / -0.38%
Today’s Change
135.94
Today|||52-Week Range
230.40
+22.06%
Year-to-Date
Bio-Rad (BIO) Scores a Strong Buy Right Now: Here's How
Jun 22 / Zacks.com - Paid Partner Content
Capital Senior Living (CSU) in Focus: Stock Moves 5.8% Higher
Jun 13 / Zacks.com - Paid Partner Content
Health Care Battle Rages On: 2 MedTech Stocks to Buy
Jun 16 / Zacks.com - Paid Partner Content
Omeros (OMER) Worth a Look: Stock Adds 11.8% in Session
Jun 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close223.35
Today’s open223.89
Day’s range221.87 - 224.23
Volume175,419
Average volume (3 months)192,492
Market cap$5.4B
Dividend yield--
Data as of 4:02pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)-75.32%
Earnings growth (this year)+200.35%
Earnings growth (next 5 years)+14.34%
Revenue growth (last year)+2.41%
P/E ratio236.7
Price/Sales2.61
Price/Book2.54

Competitors

 Today’s
change
Today’s
% change
BRKRBruker Corp+1.36+4.75%
PKIPerkinElmer Inc+0.65+0.96%
QGENQiagen NV-0.21-0.60%
AXDXAccelerate Diagnosti...-0.05-0.17%
Data as of 4:04pm ET, 06/23/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)$0.49
Annual revenue (last year)$2.1B
Annual profit (last year)$28.1M
Net profit margin1.36%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Norman D. Schwartz
Chief Operating Officer &
Executive Vice President
John Goetz
Corporate headquarters
Hercules, California

Forecasts